Skip to main content
. 2020 Nov 5;6:26. doi: 10.1186/s40959-020-00081-9

Table 5.

Multivariate analysis of hazard ratio of OS with trastuzumab discontinuation

Variable Adjusted Hazard Ratio Std. Err. 95% CI P-value
Discontinuation Trastuzumab 4.76 1.59 2.47–9.16 < 0.001
Age 0.99 0.01 0.97–1.01 0.302
Stage, 1 or 2 vs Stage 3 2.45 0.74 1.36–4.41 0.003
Grade, 1 or 2 vs Grade 3 1.69 0.53 0.91–3.14 0.094
ER status, Negative vs Positive 0.64 0.20 0.34–1.20 0.163
Cardiomyopathy Yes vs No 0.31 0.13 0.14–0.70 0.004